OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones
Diana Alemán-González-Duhart, Feliciano Tamay‐Cach, Samuel Álvarez-Almazán, et al.
PPAR Research (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

PPARγ preservation via promoter demethylation alleviates osteoarthritis in mice
Xiaobo Zhu, Fang Chen, Ke Lu, et al.
Annals of the Rheumatic Diseases (2019) Vol. 78, Iss. 10, pp. 1420-1429
Closed Access | Times Cited: 93

Di-(2-ethylhexyl) phthalate could disrupt the insulin signaling pathway in liver of SD rats and L02 cells via PPARγ
Wang Zhang, Xin Shen, Wenwen Zhang, et al.
Toxicology and Applied Pharmacology (2016) Vol. 316, pp. 17-26
Closed Access | Times Cited: 83

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
Veronica Vella, Maria Luisa Nicolosi, Stefania Giuliano, et al.
Frontiers in Endocrinology (2017) Vol. 8
Open Access | Times Cited: 75

Anti-diabetic effects of natural products an overview of therapeutic strategies
Jiyoung Park, Hyeung-Jin Jang
Molecular & Cellular Toxicology (2017) Vol. 13, Iss. 1, pp. 1-20
Closed Access | Times Cited: 49

Inhibition of DNA methylation de‐represses peroxisome proliferator‐activated receptor‐γ and attenuates pulmonary fibrosis
Wei Ai, Qi Gao, Fang Chen, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 7, pp. 1304-1318
Open Access | Times Cited: 35

Enhancing PPARγ by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice
Qi Gao, Wei Ai, Fang Chen, et al.
Pharmacological Research (2020) Vol. 160, pp. 105059-105059
Closed Access | Times Cited: 38

Diabetic Retinopathy: Important Biochemical Alterations and the Main Treatment Strategies
Amaranta Sarai ValdezGuerrero, Julio César Quintana-Pérez, Mónica Griselda Arellano-Mendoza, et al.
Canadian Journal of Diabetes (2020) Vol. 45, Iss. 6, pp. 504-511
Closed Access | Times Cited: 35

Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function—Mechanisms and Possible Therapeutic or Preventive Measures: an Update
Ann Verhaegen, Luc F. Van Gaal
Current Obesity Reports (2021) Vol. 10, Iss. 1, pp. 1-13
Closed Access | Times Cited: 32

Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update
Zhenyang Liu, Hongwei Gao, Ziyu Zhao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113990-113990
Open Access | Times Cited: 21

Unlocking Antidiabetic Potential: Novel Compounds from Endophytic Fungi Isolated from Manihot esculenta Crantz Tuberous Roots
K. Nagarajan, Mahisha Devi Chelladurai, Sugumar Mani, et al.
Journal of Molecular Structure (2025), pp. 142083-142083
Closed Access

The physiochemical characteristics of Cyclocarya paliurus polysaccharides and in vitro anti-diabetic effects of their different fractions
Ziping Zhu, Weida Lin, Junxia Ma, et al.
Industrial Crops and Products (2024) Vol. 211, pp. 118188-118188
Closed Access | Times Cited: 3

Insulin Mimetic Properties of Extracts Prepared from Bellis perennis
Renate Haselgrübler, Verena Stadlbauer, Flora Stübl, et al.
Molecules (2018) Vol. 23, Iss. 10, pp. 2605-2605
Open Access | Times Cited: 30

Gluc-HET, a complementary chick embryo model for the characterization of antidiabetic compounds
Renate Haselgrübler, Flora Stübl, Katja Essl, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0182788-e0182788
Open Access | Times Cited: 25

Discovery of Novel Insulin Sensitizers: Promising Approaches and Targets
Yadan Chen, Haiming Ma, Da-Sheng Zhu, et al.
PPAR Research (2017) Vol. 2017, pp. 1-13
Open Access | Times Cited: 24

Study of new interactions of glitazone’s stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins
Samuel Álvarez-Almazán, Martiniano Bello, Feliciano Tamay‐Cach, et al.
Biochemical Pharmacology (2017) Vol. 142, pp. 168-193
Closed Access | Times Cited: 22

Current molecular aspects in the development and treatment of diabetes
Samuel Álvarez-Almazán, Jessica Georgina Filisola-Villaseñor, Diana Alemán-González-Duhart, et al.
Journal of Physiology and Biochemistry (2020) Vol. 76, Iss. 1, pp. 13-35
Closed Access | Times Cited: 20

Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice
Yuma Ito, Masaki Fukui, Mamoru Kanda, et al.
Journal of Pharmacological Sciences (2018) Vol. 137, Iss. 1, pp. 38-46
Open Access | Times Cited: 20

Structure–Activity Relationship Study of Acyclic Terpenes in Blood Glucose Levels: Potential α-Glucosidase and Sodium Glucose Cotransporter (SGLT-1) Inhibitors
Miguel Ángel Serra Valdés, Fernando Calzada, Jessica Elena Mendieta‐Wejebe
Molecules (2019) Vol. 24, Iss. 22, pp. 4020-4020
Open Access | Times Cited: 19

Novel Hybrids of Pyrazolidinedione and Benzothiazole as TZD Analogues. Rationale Design, Synthesis and In Vivo Anti-Diabetic Evaluation
Michelyne Haroun
Medicinal Chemistry (2019) Vol. 15, Iss. 6, pp. 624-633
Closed Access | Times Cited: 18

Drugs That Affect Body Weight, Body Fat Distribution, and Metabolism
Ann Verhaegen, Luc F. Van Gaal
(2019)
Closed Access | Times Cited: 17

Why Should Growth Hormone (GH) Be Considered a Promising Therapeutic Agent for Arteriogenesis? Insights from the GHAS Trial
Diego Caicedo, Pablo Devesa, Clara V. Álvarez, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 807-807
Open Access | Times Cited: 15

Annona cherimola Miller and Its Flavonoids, an Important Source of Products for the Treatment of Diabetes Mellitus: In Vivo and In Silico Evaluations
Fernando Calzada, Miguel Ángel Serra Valdés, Jesús Martínez-Solís, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 724-724
Open Access | Times Cited: 5

Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors
Dilys T.H. Leung, Trang Nguyen, Edwina May Oliver, et al.
Molecular Cancer Therapeutics (2018) Vol. 18, Iss. 2, pp. 364-375
Open Access | Times Cited: 16

PPAR-γLigand Inhibits Nasopharyngeal Carcinoma Cell Proliferation and Metastasis by Regulating E2F2
Pingli Yang, Jiashun Wang, Xiaomei Cheng, et al.
PPAR Research (2019) Vol. 2019, pp. 1-9
Open Access | Times Cited: 15

Edema from Taking Cinnamon for Treatment of Diabetes: Similar Biochemistry and Pathophysiology to Thiazolidinedione Medications
Paul Crawford, Amanda J. Crawford
The Journal of the American Board of Family Medicine (2018) Vol. 31, Iss. 5, pp. 809-811
Open Access | Times Cited: 14

Page 1 - Next Page

Scroll to top